A low-cost recombinant glycoconjugate vaccine confers immunogenicity and protection against enterotoxigenic Escherichia coli infections in mice

Overview of attention for article published in Frontiers in Molecular Biosciences, March 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

So far, Altmetric has seen 14 X posts from 9 X users, with an upper bound of 17,212 followers.

RT @Asher__Williams: A collaborative effort with @ktwarfel⁩ ⁦@primitdesai⁩ ⁦@MichaelCJewett⁩ ⁦@mattdelisa⁩ & others - glad this story on ou…

RT @DeLisaGroup: Another step toward developing more affordable & accessible vaccines against enteric infections! Out today, our latest res…

RT @Asher__Williams: A collaborative effort with @ktwarfel⁩ ⁦@primitdesai⁩ ⁦@MichaelCJewett⁩ ⁦@mattdelisa⁩ & others - glad this story on ou…

RT @Asher__Williams: A collaborative effort with @ktwarfel⁩ ⁦@primitdesai⁩ ⁦@MichaelCJewett⁩ ⁦@mattdelisa⁩ & others - glad this story on ou…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 10 additional X posts.